Approach for Development of Topical Ketoconazole-Loaded Microemulsions and Its Antifungal Activity

Authors

  • Ornchuma Naksuriya Sun Herb Thai Chinese Manufacturing, College of Pharmacy, Rangsit University, Pathum Thani 12000, Thailand
  • Nichcha Nitthikan Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand
  • Kanittapon Supadej Department of Medical Technology, School of Allied Health Sciences, University of Phayao, Phayao 56000, Thailand
  • Kantaporn Kheawfu Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand
  • Ruttiros Khonkarn Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand
  • Chadarat Ampasavate Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand
  • Nutjeera Intasai Division of Clinical Microscopy, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand
  • Chaowalit Monton Drug and Herbal Product Research and Development Center, College of Pharmacy, Rangsit University, Pathum Thani 12000, Thailand
  • Kanokwan Kiattisin Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand

DOI:

https://doi.org/10.48048/tis.2023.7046

Keywords:

Quality by design, Ketoconazole, Microemulsions, Design of experiment, Design space, Optimization, Antifungal

Abstract

Loading ketoconazole in microemulsions can enhance the solubility and permeation of ketoconazole into the skin. The systematic approach as quality by design (QbD) can help for better product and process understanding. This study aimed to develop topical ketoconazole-loaded microemulsions (KME) based on the QbD approach. After risk assessment, the design of experiment was utilized to determine the optimal ratio of water, isopropyl myristate, and surfactant mixture (polysorbate 80 and ethanol), which were chosen as critical material attributes. The particle size and polydispersity index, selected as critical quality attributes, were evaluated as responses. Then, characterizations, in vitro permeation, cytotoxicity, and antifungal activity studies were tested. As result, the equations from the D-optimal mixture design model successfully predicted the composition of the optimized formulation and obtained the acceptable design space. The optimized KME was 16.00 % w/w of isopropyl myristate, 73.50 % w/w of surfactant mixture, and 8.50 % w/w of water resulted in a water-in-oil system. The particle size and polydispersity index of KME were 21.1 ± 1.6 nm and 0.329 ± 0.020, respectively. KME showed prolonged skin retention after 24 h and was non-toxic. KME exhibited a broader zone of inhibition and lower inhibition concentration compared to unloaded ketoconazole against dermatophytes, indicating that KME enhanced effectiveness in antifungal activity for skin infection. The results of the KME meeting the quality target indicated a well-designed and suitable microemulsion for topical usage. Therefore, employing QbD in identifying the process and formulation is a promising approach for future development of high-quality topical KME products.

HIGHLIGHTS

  • The topical ketoconazole-loaded microemulsions (KME) were developed based on quality by design approach for further industrial production
  • The D-optimal mixture design model successfully predicted the design space of desired KME formulation
  • KME showed prolonged skin retention after 24 h
  • KME was non-toxic for a topical dosage form
  • KME exhibited antifungal activity greater than unloaded ketoconazole


GRAPHICAL ABSTRACT

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

M Ivanov, A Ćirić and D Stojković. Emerging antifungal targets and strategies. Int. J. Mol. Sci. 2022; 23, 2756.

EH Endo, RY Makimori, MV Companhoni, T Ueda-Nakamura, CV Nakamura and BPD Filho. Ketoconazole-loaded poly-(lactic acid) nanoparticles: Characterization and improvement of antifungal efficacy in vitro against Candida and dermatophytes. J. Mycol. Med. 2020; 30, 101003.

AK Gupta and DC Lyons. The rise and fall of oral ketoconazole. J. Cutan. Med. Surg. 2015; 19, 352-7.

N Tiwari, A Sivakumar, A Mukherjee and N Chandrasekaran. Enhanced antifungal activity of Ketoconazole using rose oil based novel microemulsion formulation. J. Drug Deliv. Sci. Tech. 2018; 47, 434-44.

N Nema, N Singh and A Pandey. The supramicellar solutions of polymeric surfactant (PEG 400) for the determination of poorly soluble antifungal drug. Chemistry 2010; 19, 93-102.

Q Ma, J Zhang, B Lu, H Lin, R Sarkar, T Wu and X Li. Nanoemulgel for improved topical delivery of desonide: Formulation design and characterization. AAPS PharmSciTech 2021; 22, 163.

AA Halwani. Development of pharmaceutical nanomedicines: From the bench to the market. Pharmaceutics 2022; 14, 106.

AR Kirtane, M Verma, P Karandikar, J Furin, R Langer and G Traverso. Nanotechnology approaches for global infectious diseases. Nat. Nanotechnol. 2021; 16, 369-84.

S Soares, J Sousa, A Pais, C Vitorino. Nanomedicine: Principles, properties, and regulatory issues. Front. Chem. 2018; 6, 360.

T Shukla, N Upmanyu, M Agrawal, S Saraf, S Saraf and A Alexander. Biomedical applications of microemulsion through dermal and transdermal route. Biomed. Pharmacother. 2018; 108, 1477-94.

CM Hsieh, TL Yang, AD Putri and CT Chen. Application of design of experiments in the development of self-microemulsifying drug delivery systems. Pharmaceuticals 2023; 16, 283.

G Tartaro, H Mateos, D Schirone, R Angelico and G Palazzo. Microemulsion microstructure(s): A tutorial review. Nanomaterials 2020; 10, 1657.

EB Souto, A Cano, C Martins-Gomes, TE Coutinho, A Zielińska and AM Silva. Microemulsions and nanoemulsions in skin drug delivery. Bioengineering 2022; 9, 158.

L Mockus, D LeBlond, PK Basu, RB Shah and MA Khan. A QbD case study: Bayesian prediction of lyophilization cycle parameters. AAPS PharmSciTech 2011; 12, 442-8.

ICH Quality Guidelines, Available at: https://www.ich.org/page/quality-guidelines, accessed April 2023.

M Wróblewska, E Szymańska and K Winnicka. The influence of tea tree oil on antifungal activity and pharmaceutical characteristics of Pluronic® F-127 gel formulations with ketoconazole. Int. J. Mol. Sci. 2021; 22, 11326.

BG Prajapati, H Paliwal and PA Shah. In vitro characterization of self-emulsifying drug delivery system-based lipsticks loaded with ketoconazole. Future J. Pharmaceut. Sci. 2023; 9, 35.

R Khonkarn, OS Kittipongpatana, V Boasouna and S Okonogi. Enhanced UV protection of ketoconazole using Hyptis suaveolens microemulsion. Pakistan J. Pharmaceut. Sci. 2018; 31, 733-9.

P Anantaworasakul, S Anuchapreeda, S Yotsawimonwat, O Naksuriya, S Lekawanvijit, N Tovanabutra, P Anantaworasakul, W Wattanasri, N Buranapreecha and C Ampasavate. Nanomaterial lipid-based carrier for non-invasive capsaicin delivery; manufacturing scale-up and human irritation assessment. Molecules 2020; 25, 5575.

N Nitthikan, P Leelapornpisid, S Natakankitkul, W Chaiyana, M Mueller, H Viernstein and K Kiattisin. Improvement of stability and transdermal delivery of bioactive compounds in green robusta coffee beans extract loaded nanostructured lipid carriers. J. Nanotechnology 2018; 2018, 7865024.

N Nitthikan, P Leelapornpisid, O Naksuriya, N Intasai and K Kiattisin. Potential and alternative bioactive compounds from brown Agaricus bisporus mushroom extracts for xerosis treatment. Sci. Pharm. 2022; 90, 59.

Clinical and Laboratory Standards Institute, Available at: https://clsi.org/, accessed June 2023.

FF Veiga, MC Gadelha, MR Da Silva, MI Costa, B Kischkel, LVD Castro-Hoshino, F Sato, ML Baesso, MF Voidaleski, V Vasconcellos-Pontello and VA Vicente. Propolis extract for onychomycosis topical treatment: From bench to clinic. Front. Microbiol. 2018; 9,779.

AE Moskaluk and S VandeWoude. Current topics in dermatophyte classification and clinical diagnosis. Pathogens 2022; 11, 957.

J Roana, N Mandras, D Scalas, P Campagna and V Tullio. Antifungal activity of Melaleuca alternifolia essential oil (TTO) and its synergy with itraconazole or ketoconazole against Trichophyton rubrum. Molecules 2021; 26, 461.

KC Hazen. Fungicidal versus fungistatic activity of terbinafine and itraconazole: An in vitro comparison. J. Am. Acad. Dermatol. 1998; 38, S37-S41.

C Chittasupho, S Ditsri, S Singh, M Kanlayavattanakul, N Duangnin, W Ruksiriwanich and S Athikomkulchai. Ultraviolet radiation protective and anti-inflammatory effects of Kaempferia galanga L. rhizome oil and microemulsion: Formulation, characterization, and hydrogel preparation. Gels 2022; 8, 639.

L Zhao, Y Wang, Y Zhai, Z Wang, J Liu and G Zhai. Ropivacaine loaded microemulsion and microemulsion-based gel for transdermal delivery: preparation, optimization, and evaluation. Int. J. Pharm. 2014; 477, 47-56.

A Haq and B Michniak-Kohn. Effects of solvents and penetration enhancers on transdermal delivery of thymoquinone: Permeability and skin deposition study. Drug Deliv. 2018; 25, 1943-9.

TN Engelbrecht, B Demé, B Dobner and RH Neubert. Study of the influence of the penetration enhancer isopropyl myristate on the nanostructure of stratum corneum lipid model membranes using neutron diffraction and deuterium labelling. Skin Pharmacol. Physiol. 2012; 25, 200-7.

LB Lopes. Overcoming the cutaneous barrier with microemulsions. Pharmaceutics 2014; 6, 52-77.

M Herneisey, E Lambert, A Kachel, E Shychuck, JK Drennen III and JM Janjic. Quality by design approach using multiple linear and logistic regression modeling enables microemulsion scale up. Molecules 2019; 24, 2066.

A Akram, A Rasul, MK Waqas, M Irfan, SH Khalid, MN Aamir, G Murtaza, KU Rehman, M Iqbal and BA Khan. Development, characterization and evaluation of in-vitro anti-inflammatory activity of ginger extract based microemulsion. Pakistan J. Pharmaceut. Sci. 2019; 2, 1327-32.

J Cui, B Yu, Y Zhao, W Zhu, H Li, H Lou and G Zhai. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int. J. Pharm. 2009; 371, 148-55.

M Nasr, S Abdel-Hamid. Optimizing the dermal accumulation of a tazarotene microemulsion using skin deposition modeling. Drug Dev. Ind. Pharm. 2016; 42, 636-43.

N Aggarwal, S Goindi, R Khurana. Formulation, characterization and evaluation of an optimized microemulsion formulation of griseofulvin for topical application. Colloid. Surface. B Biointerfaces 2013; 105, 158-66.

M von Stosch, R Schenkendorf, G Geldhof, C Varsakelis, M Mariti, S Dessoy, A Vandercammen, A Pysik and M Sanders. Working within the design space: Do our static process characterization methods suffice? Pharmaceutics 2020; 12, 562.

M Gradzielski, M Duvail, PM de Molina, M Simon, Y Talmon and T Zemb. Using microemulsions: Formulation based on knowledge of their mesostructure. Chem. Rev. 2021; 121, 5671-740.

MD Chatzidaki, S Demisli, E Zingkou, PG Liggri, DP Papachristos, G Balatsos, V Karras, F Nallet, A Michaelakis, G Sotiropoulou and SE Zographos. Essential oil-in-water microemulsions for topical application: Structural study, cytotoxic effect and insect repelling activity. Colloid. Surface. Physicochem. Eng. Aspect. 2022; 654, 130159.

VK Rai, N Mishra, KS Yadav and NP Yadav. Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery: Formulation development, stability issues, basic considerations and applications. J. Contr. Release 2018; 270, 203-25.

AA Umar, IB Saaid, AA Sulaimon and RB Pilus. A review of petroleum emulsions and recent progress on water-in-crude oil emulsions stabilized by natural surfactants and solids. J. Petrol. Sci. Eng. 2018; 165, 673-90.

MM Mehanna, KK Abla and HA Elmaradny. Tailored limonene-based nanosized microemulsion: Formulation, physicochemical characterization and in vivo skin irritation assessment. Adv. Pharmaceut. Bull. 2021; 11, 274.

ZD Draelos. The science behind skin care: Cleansers. J. Cosmet. Dermatol. 2018; 17, 8-14.

A Hussain, A Samad, S Singh, M Ahsan, M Haque, A Faruk and F Ahmed. Nanoemulsion gel-based topical delivery of an antifungal drug: In vitro activity and in vivo evaluation. Drug Deliv. 2016; 23, 642-57.

Z Wang, HJ Mu, XM Zhang, PK Ma, SN Lian, FP Zhang, SY Chu, WW Zhang, AP Wang, WY Wang and KX Sun. Lower irritation microemulsion-based rotigotine gel: Formulation optimization and in vitro and in vivo studies. Int. J. Nanomedicine 2015; 10, 633-44.

Y Zhang, H Hu, Q Jing, Z Wang, Z He, T Wu and NP Feng. Improved biosafety and transdermal delivery of aconitine via diethylene glycol monoethyl ether-mediated microemulsion assisted with microneedles. Pharmaceutics 2020; 12, 163.

X Lv, Z Cong, Z Liu, X Ma, M Xu, Y Tian, X Zhang, B Xu, J Zhang and Z Tang. Improvement of the solubility, photostability, antioxidant activity and UVB photoprotection of trans-resveratrol by essential oil based microemulsions for topical application. J. Drug Deliv. Sci. Tech. 2018; 48, 346-54.

J Che, Z Wu, W Shao, P Guo, Y Lin, W Pan, W Zeng, G Zhang, C Wu and Y Xu. Synergetic skin targeting effect of hydroxypropyl-β-cyclodextrin combined with microemulsion for ketoconazole. Eur. J. Pharm. Biopharm. 2015; 93, 136-48.

VK Rapalli, S Banerjee, S Khan, PN Jha, G Gupta, K Dua, MS Hasnain, AK Nayak, SK Dubey and G Singhvi. QbD-driven formulation development and evaluation of topical hydrogel containing ketoconazole loaded cubosomes. Mater. Sci. Eng. C Mater. Biol. Appl. 2021; 119, 111548.

Downloads

Published

2023-09-10

How to Cite

Naksuriya, O. ., Nitthikan, N. ., Supadej, K. ., Kheawfu, K. ., Khonkarn, R. ., Ampasavate, C. ., Intasai, N. ., Monton, C. ., & Kiattisin, K. . (2023). Approach for Development of Topical Ketoconazole-Loaded Microemulsions and Its Antifungal Activity. Trends in Sciences, 20(12), 7046. https://doi.org/10.48048/tis.2023.7046